Image Credit: CFP

On Thursday, Dr. Serhat Unal, a health expert in the Turkish medical board announced that the Chinese experimental vaccine developed by the Sinovac Biotech has shown an efficacy of 91.25% in the initial results of the late-stage trials. Unlike Pfizer/BioNTech’s vaccine, Sinovac vaccine is an inactivated vaccine. This means that unlike Pfizer/BioNTech’s vaccine, a virus will be delivered to the vaccine receiver, but the virus is inactivated and therefore would not pose any danger of infection for the receiver. This type of vaccine is technically a historically proven approach as most vaccines use this approach.

On Monday, Turkey will receive the first shipment of three million doses of the Chinese vaccine, CoronaVac. Initially, the vaccine was planned to be received after December 11, but due to permit problems, the vaccine delivery was delayed. Turkey will receive a total of 50 million doses of the vaccine. The country…